HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stefan Pöhlmann Selected Research
Stefan Pöhlmann Research Topics
Disease
73
Infections
04/2024 - 04/2002
47
COVID-19
04/2024 - 01/2020
19
Virus Diseases (Viral Diseases)
03/2024 - 11/2004
12
Vesicular Stomatitis
03/2024 - 06/2004
7
Human Influenza (Influenza)
01/2022 - 07/2009
5
Severe Acute Respiratory Syndrome
01/2022 - 06/2004
5
Ebola Hemorrhagic Fever
04/2021 - 08/2002
4
Coronavirus Infections
01/2023 - 09/2014
3
Lung Injury
01/2022 - 01/2010
3
Inflammation (Inflammations)
01/2022 - 01/2021
3
Filoviridae Infections
01/2019 - 11/2004
3
Acquired Immunodeficiency Syndrome (AIDS)
01/2013 - 01/2006
2
Breakthrough Infections
11/2022 - 11/2022
2
Hemorrhage
01/2022 - 11/2021
2
Critical Illness (Critically Ill)
12/2021 - 01/2021
2
Neoplasms (Cancer)
01/2019 - 07/2009
2
Fever (Fevers)
04/2013 - 11/2011
1
Convalescence
04/2024
1
Fatigue
02/2024
1
RNA Virus Infections
10/2022
1
Fibrosarcoma
01/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Weight Loss (Weight Reduction)
01/2022
1
HIV Infections (HIV Infection)
01/2022
1
Hypoxia (Hypoxemia)
12/2021
1
Lymphopenia (Lymphocytopenia)
12/2021
1
Chronic Kidney Failure (Chronic Renal Failure)
12/2021
Drug/Important Bio-Agent (IBA)
28
Antiviral Agents (Antivirals)
IBA
01/2023 - 11/2011
26
Proteins (Proteins, Gene)
FDA Link
03/2024 - 06/2004
17
Antibodies
IBA
04/2024 - 06/2004
17
Peptide Hydrolases (Proteases)
FDA Link
03/2021 - 01/2006
15
Vaccines
IBA
11/2022 - 05/2005
15
DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)
IBA
10/2020 - 08/2002
14
Glycoproteins (Glycoprotein)
IBA
01/2024 - 09/2002
9
Neutralizing Antibodies
IBA
11/2022 - 06/2004
8
Serine Proteases (Serine Protease)
IBA
01/2023 - 07/2009
7
Interferons
IBA
01/2023 - 01/2017
7
Lectins
IBA
10/2020 - 08/2002
6
camostat
IBA
01/2022 - 04/2015
6
Bone Marrow Stromal Antigen 2
IBA
01/2019 - 11/2011
5
BNT162 Vaccine
IBA
11/2022 - 01/2021
5
SARS-CoV-2 spike protein
IBA
01/2022 - 11/2020
4
Messenger RNA (mRNA)
IBA
04/2024 - 01/2021
4
Monoclonal Antibodies
IBA
03/2024 - 10/2021
4
bamlanivimab
IBA
01/2022 - 01/2021
4
Sphingomyelin Phosphodiesterase (Sphingomyelinase)
IBA
01/2021 - 11/2020
4
Polysaccharides (Glycans)
IBA
10/2020 - 01/2008
4
C-Type Lectins (C-Type Lectin)
IBA
07/2011 - 01/2003
3
Angiotensin-Converting Enzyme 2
IBA
01/2023 - 07/2004
3
N-(2-cyanoethylene)urea (BA 1)
IBA
01/2023 - 10/2022
3
Acids
IBA
01/2021 - 11/2020
3
Ceramides
IBA
01/2021 - 11/2020
3
Enzymes
IBA
11/2020 - 12/2011
3
Sialic Acids
IBA
01/2018 - 10/2010
2
N-methyl-valyl-amiclenomycin (BA 2)
IBA
01/2023 - 10/2022
2
dalbavancin
IBA
09/2022 - 01/2021
2
Cytokines
IBA
01/2022 - 10/2011
2
Antioxidants
IBA
01/2022 - 11/2021
2
Amino Acids
FDA Link
01/2022 - 09/2006
2
Cysteamine (Mercaptamine)
FDA Link
01/2022 - 11/2021
2
Sulfhydryl Compounds (Thiols)
IBA
01/2022 - 11/2021
2
sphingosine kinase
IBA
12/2021 - 04/2021
2
Ac-GQFR-kbt
IBA
10/2021 - 05/2021
2
3,5-diisopropylsalicylic acid (DIPS)
IBA
10/2021 - 01/2021
2
nafamostat
IBA
10/2021 - 01/2020
2
Protease Inhibitors (Protease Inhibitor)
IBA
03/2021 - 08/2020
2
Amitriptyline (Elavil)
FDA Link
Generic
01/2021 - 11/2020
2
Antidepressive Agents (Antidepressants)
IBA
01/2021 - 11/2020
2
Ligands
IBA
01/2021 - 01/2017
2
Antigens
IBA
11/2020 - 03/2020
2
Carbohydrates
IBA
10/2020 - 01/2017
1
Immunoglobulins (Immunoglobulin)
IBA
04/2024
1
Epitopes
IBA
06/2023
1
Fondaparinux (Arixtra)
FDA Link
01/2023
1
Antithrombins
IBA
01/2023
1
Heparin (Liquaemin)
FDA Link
Generic
01/2023
1
Anticoagulants
IBA
01/2023
1
Serine Proteinase Inhibitors (Serine Protease Inhibitors)
IBA
01/2023
1
COVID-19 Vaccines
IBA
11/2022
1
molnupiravir
IBA
10/2022
1
cilgavimab
IBA
10/2022
1
sotrovimab
IBA
10/2022
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022
1
2- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acid
IBA
01/2022
1
Mitogen-Activated Protein Kinases
IBA
01/2022
1
Phosphotransferases (Kinase)
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
Peptidomimetics
IBA
01/2022
1
pol Gene Products
IBA
01/2022
1
imdevimab
IBA
01/2022
1
Aerosols
IBA
01/2022
1
Lipids
IBA
12/2021
1
sphingosine 1-phosphate (sphingosine-1-phosphate)
IBA
12/2021
1
HDL Lipoproteins
IBA
12/2021
1
Lyases
IBA
12/2021
1
Serum Albumin
IBA
12/2021
1
2019-nCoV Vaccine mRNA-1273
IBA
12/2021
1
otamixaban
IBA
10/2021
Therapy/Procedure
15
Therapeutics
01/2023 - 08/2002